Back to video list Back to Home How would you choose which CGRP pathway monoclonal antibody medication is for which patient and how do you convince the patient to be on eptinezumab? You may also like Mental Health Congress highlights Article Highlights from ECNP 2022 – Day 2 – October 16th Alzheimer's Disease Article Transforming the Alzheimer’s Landscape: A Narrative on Diagnosis, Biomarkers, Therapeutic Advances, and Prevention — Highlight from ASAD 2025 Schizophrenia Article Schizophrenia in the near future Parkinson's Disease Article New therapeutic technologies and targets for Parkinson’s disease